Oric Pharmaceuticals share price logo

Oric Pharmaceuticals Share Price

NASDAQ: ORIC

Small Cap

$10.85

+0.07

(+0.65%)

Live

as on

Oric Pharmaceuticals Stock Performance

as on September 16, 2025 at 12:38 am IST

  • Day's Low

    Day's High

    $10.72
    $11.16
    downward going graph

    1.20%

    Downside

    2.86%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.9
    $14.67
    downward going graph

    64.10%

    Downside

    35.21%

    Upside

    downward going graph

Oric Pharmaceuticals share price movements today

Previous Close
$10.78
Open
$10.90
Volume
923.2K
Day's Low - High
$10.72 - $11.16
52 Week Low - High
$3.9 - $14.67

Oric Pharmaceuticals Historical Returns

1 Month Return
+ 11.59 %
3 Month Return
+ 11.94 %
1 Year Return
+ 9 %
3 Year Return
+ 220.83 %
5 Year Return
-50.21 %

Oric Pharmaceuticals Stock Fundamentals & Key Indicators

Check Oric Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.0B

EPS (TTM)

-1.7062

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-148.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

134083300.00%

Oric Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oric Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.0B-50.21%NA0.00%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Oric Pharmaceuticals Stock including INR - Dollar returns

The Oric Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Oric Pharmaceuticals investment value today

Current value as on today

₹1,14,692

Returns

₹14,692

(+14.69%)

Returns from Oric Pharmaceuticals Stock

₹9,707 (+9.71%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Oric Pharmaceuticals Stock

Based on 15 analysts

BUY

93.33%

Buy

6.67%

Hold

0.00%

Sell

Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Oric Pharmaceuticals. Average target price of $18

Oric Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Oric Pharmaceuticals.

What analysts predicted

39.72%UPSIDE

Target Price

$18

Current Price

$10.85

Analyzed by

15 Analysts

Target

$18.00

Oric Pharmaceuticals target price $18, a slight upside of 39.72% compared to current price of $10.85. According to 15 analysts rating.

Oric Pharmaceuticals Stock's Interest Amongst Investors

Search interest for Oric Pharmaceuticals Stock has increased by 129% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:129% versus previous 30 day period

Oric Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
1
-
-
-
1
-
-
Gross Profit
0
0
0
1
0
0
0
0
0
0
Operating Income
-25
-24
-28
-31
-28
-36
-38
-39
-32
-39
EBITDA
-25
-24
-28
-31
-28
-35
-38
-39
-32
-39
Interest Expense
1
-
-
1
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-23
-22
-25
-28
-25
-31
-34
-36
-30
-36
Income Tax Expense
-1
0
0
2
0
0
-
-
-
-
Net Income
-21
-22
-25
-28
-25
-31
-34
-36
-30
-36
Net Profit Margin
0.00%
0.00%
0.00%
-1842.00%
0.00%
0.00%
0.00%
-3405.91%
0.00%
0.00%

Oric Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
-
Gross Profit
0
-1
0
0
0
-1
-1
Operating Income
-22
-28
-74
-78
-91
-110
-142
EBITDA
-20
-27
-72
-77
-88
-109
-126
Interest Expense
1
1
0
0
2
-
-
Depreciation
0
1
0
0
0
1
1
Income Before Tax
-21
-26
-73
-78
-89
-100
-127
Income Tax Expense
-1
-1
23
-1
2
-
-
Net Income
-21
-26
-73
-77
-89
-100
-127
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Oric Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-22
-25
-28
-25
-31
-34
-36
-30
-36
Operating Cash Flow
-21
-19
-24
-30
-25
-28
-28
-32
-30
Investing Cash Flow
-19
-57
20
-61
18
23
42
22
-76
Financing Cash Flow
85
0
0
125
0
0
0
0
134
Change in Cash
44
-77
-2
32
-6
-5
15
-10
26

Oric Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-21
-26
-73
-78
-89
-100
-127
Operating Cash Flow
-20
-23
-45
-59
-75
-85
-112
Investing Cash Flow
0
0
-215
158
-109
-43
22
Financing Cash Flow
38
70
250
49
25
85
126
Change in Cash
16
46
-10
148
-159
-43
36

Global Institutional Holdings in Oric Pharmaceuticals

Funds
Holdings
Viking Global Investors LP
7.71%
BlackRock Inc
6.38%
Pfizer Inc
6.31%
Nextech Invest, Ltd.
6.2%
Alkeon Capital Management, LLC
4.7%

Insights on Oric Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, ORIC stock has moved up by 220.8%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ORIC has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 66.6%

About Oric Pharmaceuticals

oric pharmaceuticals, inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers. its lead product candidate is oric-101, a small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across various solid tumors. the company's second product candidate is oric-533, an orally bioavailable small molecule inhibitor of cd73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. it is also developing multiple precision medicines targeting other cancer resistance mechanisms. the company was founded in 2014 and is headquartered in south san francisco, california.
OrganisationOric Pharmaceuticals
Headquarters240 East Grand Avenue, South San Francisco, CA, United States, 94080
IndustryHealth Technology
CEODr. Jacob M. Chacko M.B.A., M.D.
E-voting on sharesClick here to vote

Key Management of Oric Pharmaceuticals

Name

Title

Dr. Jacob M. Chacko M.B.A., M.D.

President, CEO & Director

Dr. Pratik S. Multani M.D., M.S.

Chief Medical Officer

Dr. Scott W. Lowe Ph.D.

Founder & Member of Scientific Advisory Board

Dr. Kevin Brodbeck Ph.D.

Chief Technical Officer

Dr. Lori Sickels Friedman Ph.D.

Chief Scientific Officer

Dr. Richard A. Heyman Ph.D.

Founder, Independent Chairman & Member of Scientific Advisory Board

Mr. Dominic G. Piscitelli CPA, M.B.A.

Chief Financial Officer

Dr. Charles L. Sawyers B.A., M.D., Ph.D.

Founder & Member of Scientific Advisory Board

Dr. Christian V. Kuhlen Esq., J.D., M.D.

General Counsel

Mr. Daniel Iazzetti

VP & Head of People

FAQs

What is Oric Pharmaceuticals share price today?

Oric Pharmaceuticals share price today is $10.85 as on . Oric Pharmaceuticals share today touched a day high of $11.16 and a low of $10.72.

What is the 52 week high and 52 week low for Oric Pharmaceuticals share?

Oric Pharmaceuticals share touched a 52 week high of $14.67 on and a 52 week low of $3.9 on . Oric Pharmaceuticals stock price today i.e. is trending at $10.85,which is 26.04% down from its 52 week high and 178.56% up from its 52 week low.

What is Oric Pharmaceuticals's market capitalisation today?

Oric Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Oric Pharmaceuticals Stock (ORIC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Oric Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oric Pharmaceuticals Shares that will get you 0.1382 shares as per Oric Pharmaceuticals share price of $10.85 per share as on September 16, 2025 at 12:38 am IST.

What is the minimum amount required to buy Oric Pharmaceuticals Stock (ORIC) from India?

Indian investors can start investing in Oric Pharmaceuticals (ORIC) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Oric Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Oric Pharmaceuticals share’s latest price of $10.85 as on September 16, 2025 at 12:38 am IST, you will get 0.9217 shares of Oric Pharmaceuticals. Learn more about fractional shares .

What are the returns that Oric Pharmaceuticals has given to Indian investors in the last 5 years?

Oric Pharmaceuticals stock has given -50.21% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?